We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
The current ALKS market cap is 5.15B. The company's latest EPS is USD 2.1987 and P/E is 14.35.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 380.94M | 377.48M | 350.37M | 399.13M | 378.14M |
| Operating Income | 43.85M | 178.58M | 43.31M | 109.88M | 104.76M |
| Net Income | 47.76M | 112.78M | 36.83M | 91.36M | 92.38M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 1.17B | 1.04B | 1.17B | 1.11B | 1.66B |
| Operating Income | -175.48M | -112.43M | -29.29M | -142.27M | 414.12M |
| Net Income | -196.62M | -110.86M | -48.17M | -158.27M | 355.76M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 2.28B | 2.14B | 2.12B | 2.21B | 2.16B |
| Total Liabilities | 923.65M | 933.54M | 869.13M | 922.84M | 863.19M |
| Total Equity | 1.36B | 1.2B | 1.25B | 1.28B | 1.29B |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 1.81B | 1.95B | 2.02B | 1.96B | 2.14B |
| Total Liabilities | 719.96M | 882.75M | 911.9M | 920.23M | 933.54M |
| Total Equity | 1.09B | 1.07B | 1.11B | 1.04B | 1.2B |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 294.12M | 401.35M | 21.11M | 167.14M | 248.73M |
| Investing | 74.34M | 53.36M | -39.95M | 11.9M | -97.43M |
| Financing | -13.22M | -289.71M | -17.87M | -101.36M | -212.47M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 72.08M | 82.84M | 101.72M | 21.04M | 401.35M |
| Investing | -141.83M | -11.48M | -66.2M | -64.54M | 53.36M |
| Financing | 6.77M | -2.17M | 29.07M | -1.57M | -289.71M |
| Market Cap | 5.15B |
| Price to Earnings Ratio | 14.35 |
| Price to Sales Ratio | 3.07 |
| Price to Cash Ratio | 11.16 |
| Price to Book Ratio | 4.25 |
| Dividend Yield | - |
| Shares Outstanding | 161.8M |
| Average Volume (1 week) | 1.39M |
| Average Volume (1 Month) | 1.36M |
| 52 Week Change | 12.63% |
| 52 Week High | 32.88 |
| 52 Week Low | 22.90 |
| Spread (Intraday) | 0.13 (0.41%) |
| Company Name | Alkermes PLC |
| Address |
connaught house dublin D04 C5Y6 |
| Website | https://www.alkermes.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
